Table 2. Characteristics of specimens from dengue patients included in the panel to evaluate anti-DENV IgM detection kits.
Panel | Region | Dengue infection* | Serotype | Acute¶ | Convalescent# | Not defined | Subtotal | Total |
IgM | America | Secondary | D1 | 29 | 29 | |||
D2 | 26 | 26 | ||||||
D3 | 17 | 17 | ||||||
D4 | 8 | 8 | ||||||
Subtotal | 80 | 80 | 80 | |||||
Asia | Primary | D1 | 8 | 8 | ||||
D2 | 3 | 3 | ||||||
D3 | 16 | 16 | ||||||
DF | 1 | 3 | 4 | |||||
DHF | 4 | 4 | ||||||
Subtotal | 28 | 7 | 35 | 35 | ||||
Secondary | D1 | 15 | 15 | |||||
D2 | 10 | 10 | ||||||
D3 | 5 | 17 | 22 | |||||
D4 | 4 | 19 | 4 | 27 | ||||
Not defined | 4 | 35 | 39 | |||||
Subtotal | 28 | 81 | 4 | 113 | 113 | |||
Total | 56 | 168 | 4 | 228 | 228 |
DENV = dengue virus.
*Primary = 1 DENV infection, Secondary ≥2 DENV infections.
days post onset of fever = 0–5.
days post onset of fever = 6–14.